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Abstract
Background: Community-acquired bacterial meningitis due to Klebsiella pneumoniae has mainly been described in
Southeast Asia and has a poor prognosis. Severe invasive infections caused by K. pneumoniae, including meningitis,
are often due to hypervirulent strains (hvKP), which are characterized by capsular serotypes K1 and K2, a gene
responsible for hypermucoviscosity, and the cluster for synthesis of the siderophore aerobactin.
Case presentation: A 55 year old man with a history of essential hypertension, benign prostate hyperplasia,
hyperlipidemia, obstructive sleep apnea, and chronic alcoholism was admitted for meningitis due to Klebsiella
pneumoniae with a wild-type susceptibility profile. Its genomic features were consistent with a capsular K2 strain
belonging to clonal group 86 (CG86) displaying the large virulence of Klebsiella plasmid (pLVPK) with heavy metal
resistance gene clusters, aerobactin, rmpA.
Conclusion: This is the first case of community-acquired meningitis caused by a hypervirulent strain of hvKP ever
reported in the Caribbean.
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Background
Klebsiella pneumoniae is an uncommon cause of
community-acquired bacterial meningitis [1, 2]. A new
group of severe infections due to hypervirulent strains
of Klebsiella pneumoniae has been described in the
past few years, mainly in Southeast Asia, including liver
abscesses, pneumonia, meningitis, metastatic localisa-
tions [2, 3] and has a poor prognosis [4]. Severe invasive
infections caused by K. pneumoniae, including meningi-
tis, are often due to hvKP. The genomic analysis of those
strains most frequently highlights capsular serotypes K1
and K2 and the presence of a large virulence plasmid
harboring the regulator of mucoid phenotype gene
rmpA, responsible for hypermucoviscosity, and the clus-
ter for synthesis of the siderophore aerobactin [5–7].
A 55-year-old man was admitted to the emergency
room of the University Hospital of Pointe-à-Pitre,
Guadeloupe, French West Indies, on July 14th, 2014, be-
cause of consciousness deterioration and photophobia.
He was born and had always lived in Guadeloupe. He
had a history of essential hypertension, benign prostate
hyperplasia, hyperlipidemia, obstructive sleep apnea, and
chronic alcoholism but he neither had cirrhosis nor dia-
betes. On July 10th, he was given amoxicillin-clavulanate
orally for an acute suppurative left otitis media without
microbiological documentation. At the time of admis-
sion, he was afebrile and hemodynamically stable, but
otoscopy revealed a persisting suppurative otitis media
and neurological examination showed a stiff neck. White
blood cell count was 11.6G/L and serum C-reactive pro-
tein was 414 mg/L. Computed tomography (CT) scan of
the brain was normal. Cerebrospinal fluid (CSF) was
cloudy, with the following abnormalities: glucose below
limit of detection, protein 8.38 g/L, and 5,500 white
blood cells (WBC)/mm3, (90% of polymorphonuclear
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(PMN) cells). Many Gram-negative bacilli were observed
on direct microscopy and CSF culture grew hypermu-
coviscous KP with a wild-type susceptibility profile. Im-
mediately after lumbar puncture, intravenous cefotaxime
(4 g qid) was started and the patient was transferred to
the intensive care unit. CT-scan of the brain showed a
left mastoiditis and CT-scan of the abdomen was nor-
mal, with no liver abscess. On July 16th, brain magnetic
resonance imaging (MRI) FLAIR sequences showed dif-
fuse subcortical hypointense signal abnormalities of the
supratentorial zone, which was consistent with a poster-
ior reversible encephalopathy syndrome without edema
probably related to undertreated high blood pressure
and exacerbated by the sepsis. On July 18th, repeat lum-
bar puncture yielded cloudy CSF with improved parame-
ters: glucose 4.8 mmol/L, protein 3.0 g/L, 3,093 WBC/
mm3 (87% of PMN cells). A few Gram-negative bacilli
were noted on direct microscopy but the culture
remained negative. Cefotaxime (4 g qid) was continued
for a total of 21 days and the patient recovered progres-
sively. When he was discharged from hospital, he still
had multiple paresis of cranial nerves (III, VI, and VII)
and hemiparesia. When he was re-evaluated 3 weeks
later all symptoms had disappeared and neurological
examination had returned to normal.
Case presentation
To determine the genotypic characteristics of the KP
isolate (SB4936), a genomic sequence was obtained
using an Illumina 2 x 300 nt paired end protocol on a
MiSeq instrument. Reads were assembled de-novo
using CLCbio assembler. The genomic sequence was
submitted to the European Nucleotide Archive (acces-
sion number PRJEB9692). Contigs were scanned using
the BIGSdb tool (http://bigsdb.pasteur.fr) for core gen-
ome multilocus sequence typing (cgMLST) as well as
KP virulence and resistance genes [8, 9]. Phylogenetic
analysis of gene sequences showed that the strain be-
longs to KP sensu stricto [10]. Consistent with this, the
genome sequence harbored the marker Kp50233, previ-
ously shown to be specific for KP [11]. Analysis of the
7-gene Multilocus sequence typing (MLST) sequences
[12] showed that the isolate belongs to sequence type
(ST) 86, the archetype ST of clonal group (CG) 86, pre-
viously recovered from severe community-acquired in-
fections [9, 13]. Furthermore, comparisons of the 694
cgMLST genes revealed only 19 allelic mismatches
when compared to reference strain SA1 of ST86, which
demonstrates that isolate SB4936 belongs to CG86 [9,
13]. Consistently, the genome also harbored genes kpiA
and nikA2, which are typical for this clonal group [11].
It also possessed the following virulence factors: rmpA
and rmpA2 (regulator of mucoid phenotype, associated
with the hypermucoviscous phenotype), iroBCDN (coding
for salmochelin), iucABCDiutA (coding for the aerobactin
siderophore cluster), kvgAS (a two-component system),
mrkABCDFHIJ (coding for the cluster for type III fim-
briae involved in adhesion and biofilm formation). Con-
versely the kfuABC (iron aquisition) and allABCDRS
(allantoin utilization) clusters were absent from its gen-
ome. The strain also possessed gene sequences wzi-2
and wzc-2, previously shown to be specifically encoun-
tered in strain of capsular serotype K2, another import-
ant virulence factor of KP. The strain did not harbor the
irp1 and irp2 genes coding for polyketide synthase/non
ribosomal peptide synthetase associated with yersinibac-
tin siderophore synthesis. No resistance gene other than
blaSHV-1 was detected in the genome of SB4936 which
was consistent with the antimicrobial susceptibility pro-
file (resistance to only ampicillin, ticarcillin and pipera-
cillin). The genomic features of isolate SB4936 were
consistent with a hypervirulent strain with a wild-type
susceptibility profile, as previously described for isolates
of clonal group CG86 [8, 9, 11, 14]. The strain also har-
bored the heavy metal resistance gene clusters pbr (lead),
pco (copper), sil (silver) and ter (tellurium). The pres-
ence of these clusters as well as of rmpA and the aero-
bactin cluster demonstrates the presence in SB4936 of a
plasmid similar to pLVPK, the large virulence plasmid of
K. pneumoniae [5]. Overall, 249 out of 251 protein-
coding genes of pLVPK were present in SB4936, among
which 237 were 100% identical in nucleotide sequence.
Conclusion
We report the second case of invasive infection due to
a hypervirulent community-acquired strain of KP ever
identified in the Caribbean area [15] and the first case
of community-acquired meningitis, possibly signaling
its emergence in this part of the world.
The clinical presentation was similar to that of other pub-
lished cases of meningitis caused by this strain [3, 7, 16].
Diabetes mellitus, liver cirrhosis and alcoholism have all
been reported as the most significant risk factors for K.
pneumoniae invasive severe infections [1, 2]. As in most
other cases of meningitis due to hypervirulent KP it was
community-acquired [7, 16]. This case report demon-
strates that hypermucoviscous strains of K. pneumoniae
have spread to the Caribbean. Therefore we would rec-
ommend that clinicians as well as microbiologists from
this region be prepared to specifically investigate strains
isolated from patients presenting with severe invasive
community-acquired K. pneumoniae infections.
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